Target
Cannabinoid receptor 2
Ligand
BDBM208325
Substrate
n/a
Meas. Tech.
cAMP Assay
EC50
>10000±n/a nM
Citation
 DeCorte, BMacielag, MGreco, MZhang, YTeleha, C Quinoline derivatives useful as CB-1 inverse agonists US Patent  US9266835 Publication Date 2/23/2016 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM208325
Synonyms:
US9266835, 25
Type:
Small organic molecule
Emp. Form.:
C27H19ClN2OS
Mol. Mass.:
454.971
SMILES:
Clc1ccc(cc1)C(c1nccs1)c1ccc2[nH]c(=O)cc(\C=C\c3ccccc3)c2c1
Structure:
Search PDB for entries with ligand similarity: